-transparent.png){kind=logo}
Nine individuals between 15 and 43 years of age with non-Hodgkin's lymphoma underwent allogeneic marrow transplantation following busulfan 16 mg/kg and cyclophosphamide 120 mg/kg. These individuals were not considered optimal candidates for autologous transplantation chiefly because of marrow involvement or resistance to chemotherapy. All patients engrafted and eight achieved complete remission. Three patients relapsed; one patient died of transplant-related complications. Five individuals are disease-free survivors between 103 and 1169 days following transplantation. Of three individuals with relapsed Burkitt's lymphoma none experienced a sustained disease-free interval following transplantation. Three of four individuals with large cell or lymphoblastic lymphoma are surviving 585 to 1169 days following transplantation. Allogeneic marrow transplantation following busulfan and cyclophosphamide appears reasonably safe and is effective in selected patients with non-Hodgkin's lymphoma who are not good candidates for autologous marrow transplantation.
E A Copelan, and
N Kapoor, and
B Gibbins, and
P J Tutschka
February 1995,
Bone marrow transplantation,
E A Copelan, and
N Kapoor, and
B Gibbins, and
P J Tutschka
December 1993,
Bone marrow transplantation,
E A Copelan, and
N Kapoor, and
B Gibbins, and
P J Tutschka
September 1997,
Bone marrow transplantation,
E A Copelan, and
N Kapoor, and
B Gibbins, and
P J Tutschka
April 1983,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
E A Copelan, and
N Kapoor, and
B Gibbins, and
P J Tutschka
June 1998,
Bone marrow transplantation,
E A Copelan, and
N Kapoor, and
B Gibbins, and
P J Tutschka
April 2000,
Lancet (London, England),
E A Copelan, and
N Kapoor, and
B Gibbins, and
P J Tutschka
September 2000,
British journal of haematology,
E A Copelan, and
N Kapoor, and
B Gibbins, and
P J Tutschka
January 2005,
British journal of haematology,
E A Copelan, and
N Kapoor, and
B Gibbins, and
P J Tutschka
June 1987,
The New England journal of medicine,
E A Copelan, and
N Kapoor, and
B Gibbins, and
P J Tutschka
January 1990,
The American journal of medicine,
